📰 Qualified Settlement News
Page 2 - Qualified Settlement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Qualified Settlement. Real-time updates on events, politics, business and more.
May 5, 2022
DUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financial
May 5, 2022
/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter...
February 28, 2022
/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and...
February 28, 2022
DUBLIN, Feb. 28, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and introduced first-quarter
February 28, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
February 3, 2022
/PRNewswire/ -- Today, Angeion Group LLC announced the expansion of its securities team with the addition of securities and distribution professionals Brett...
February 3, 2022
/PRNewswire/ -- Today, Angeion Group LLC announced the expansion of its securities team with the addition of securities and distribution professionals Brett...
November 4, 2021
/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2021. "We delivered strong...
November 4, 2021
DUBLIN, Nov. 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2021. "We delivered strong third-quarter
May 6, 2021
Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance DUBLIN, May 6, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. "I am proud of the continued strong execution across each of Endos business segments as reflected by our better than expected first-quarter 2021 results. During the quarter, our Branded Pharmaceuticals segment returned to growth, driven by strong demand for XIAF...